Ryan Saadi
Chairman
Tevogen Inc. (TVGN)Equibles does not estimate personal net worth.
Get an email with a short summary when Tevogen Inc. publishes a filing, an earnings call transcript or a press release.
Get TVGN alertsAbout Ryan Saadi
Ryan Saadi is recorded as Chairman at Tevogen Inc. (TVGN) since February 14, 2024 and CEO at Tevogen Inc. (TVGN). Tevogen Inc. reported in an 8-K filed February 14, 2024 that Ryan Saadi was appointed Chairperson, effective February 14, 2024. Tevogen Inc. reported in an 8-K filed February 14, 2024 that Ryan Saadi was appointed Chief Executive Officer, Chairperson and Director Nominee, effective February 14, 2024. The proxy statement of Tevogen Inc. reports total compensation of $10,421,000 for Ryan Saadi in fiscal 2025, including a base salary of $501,000. Disclosed compensation is on record for 3 fiscal years. Tevogen Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tevogen Inc. includes Dr. Ryan Saadi (CEO and Board Member), Surendra Ajjarapu (CEO and Board Member), Francis Knuettel II (Chairman and CFO) and 7 others.
“Dr. Ryan Saadi | 59 | Chief Executive Officer, Chairperson and Director Nominee”
“The following persons are serving as executive officers and directors of the Company effective as of the Closing Date, with each of the directors having been elected by the Semper Paratus stockholders and each of the executive officers having been appointed by the Semper Paratus Board, and ratified by the Tevogen Board, effective as of the Closing Date.”
Affiliation history
-
Current
2024-02-14–present
-
Current
Company network
Leadership on record at Tevogen Inc.
- Dr. Ryan Saadi CEO, Board Member
- Surendra Ajjarapu CEO, Board Member
- Francis Knuettel II Chairman, CFO
- Jeff Rogers CFO
- Kirti Desai CFO
- Avinaesh Wadhwani Board Member
- Curtis Patton Board Member
- Donald Fell Board Member
- Dr. Curtis Patton Board Member
- Dr. Keow Lin Goh Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tevogen Inc. (TVGN) | M.D., M.P.H. Chief Executive Officer | $501,000 | $10,421,000 |
| 2024 | Tevogen Inc. (TVGN) | M.D., M.P.H. Chief Executive Officer | $501,000 | $87,764,783 |
| 2023 | Tevogen Inc. (TVGN) | M.D., M.P.H. Chief Executive Officer | $501,000 | $501,000 |